MetLife Investment Advisors »

Taro Pharmaceutical Industries shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $181k 4.3k 41.78
2023-09-30 $164k 4.3k 37.71
2023-06-30 $165k 4.3k 37.93

More positions owned by MetLife Investment Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Vanguard Short-term Bond Index Fun Short Trm Bond (BSV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)

View all positions for MetLife Investment Advisors

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries